aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update

Go back to  aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update

aTyr Pharma (LIFE) Misses Q4 EPS by 3c

March 14, 2022 4:00 PM EDT

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

... More